Metagenomi Therapeutics, Inc.
MGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001785279
In the last 90 days, Metagenomi Therapeutics, Inc. insiders filed 1 open-market purchase and 3 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $7.45M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Metagenomi Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +50 vs. Q4 2023
- Shares held
- 13.3M
- +13.3M vs. Q4 2023
- Total value
- $140.3M
- +$140.3M vs. Q4 2023
- New holders
- 50
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $7.45M |
| Q1 2026 | 48 | $8.65M |
| Q4 2025 | 56 | $11.0M |
| Q3 2025 | 58 | $14.2M |
| Q2 2025 | 69 | $10.4M |
| Q1 2025 | 79 | $13.5M |
| Q4 2024 | 77 | $38.8M |
| Q3 2024 | 67 | $25.3M |
| Q2 2024 | 54 | $49.6M |
| Q1 2024 | 50 | $140.3M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Metagenomi Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 1,744,415 | $18.4M | 0.23% | +1,744,415 | New |
| Novo Holdings A/S | 1,739,175 | $18.3M | 1.27% | +1,739,175 | New |
| Farallon Capital Management, L.L.C. | 1,343,201 | $14.2M | 0.08% | +1,343,201 | New |
| PFM Health Sciences, LP | 1,267,002 | $13.4M | 0.66% | +1,267,002 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 777,768 | $8.21M | 0.18% | +777,768 | New |
| Millennium Management LLC | 747,548 | $7.57M | 0.01% | +747,548 | New |
| Citadel Advisors LLC | 723,901 | $7.52M | 0.01% | +723,901 | New |
| Eventide Asset Management, LLC | 583,041 | $6.15M | 0.10% | +583,041 | New |
| Sozo Ventures GP II, L.P. | 581,577 | $6.14M | 2.09% | +581,577 | New |
| Deep Track Capital, LP | 466,232 | $4.92M | 0.14% | +466,232 | New |
| Pura Vida Investments, LLC | 461,283 | $4.87M | 3.31% | +461,283 | New |
| Point72 Asset Management, L.P. | 371,100 | $3.92M | 0.01% | +371,100 | New |
| Principal Financial Group Inc | 350,859 | $3.70M | 0.00% | +350,859 | New |
| Artal Group S.A. | 300,000 | $3.17M | 0.08% | +300,000 | New |
| Frazier Life Sciences Management, L.P. | 279,025 | $2.94M | 0.12% | +279,025 | New |
| ExodusPoint Capital Management, LP | 227,556 | $2.40M | 0.03% | +227,556 | New |
| Marshall Wace, LLP | 183,027 | $1.93M | 0.00% | +183,027 | New |
| Vanguard Group Inc | 179,547 | $1.89M | 0.00% | +179,547 | New |
| Altitude Crest Partners Inc. | 133,333 | $1.41M | 0.60% | +133,333 | New |
| Ghisallo Capital Management LLC | 125,000 | $1.32M | 0.15% | +125,000 | New |
| BlackRock Inc. | 114,324 | $1.21M | 0.00% | +114,324 | New |
| Norges Bank | 107,892 | $1.14M | 0.00% | +107,892 | New |
| Geode Capital Management, LLC | 86,763 | $915.3K | 0.00% | +86,763 | New |
| Hudson Bay Capital Management LP | 66,666 | $703.3K | 0.01% | +66,666 | New |
| LMR Partners LLP | 52,058 | $549.2K | 0.01% | +52,058 | New |
| HRT Financial LP | 31,477 | $332.0K | 0.00% | +31,477 | New |
| Charles Schwab Investment Management Inc | 30,148 | $318.1K | 0.00% | +30,148 | New |
| Squarepoint Ops LLC | 26,488 | $279.4K | 0.00% | +26,488 | New |
| Bramshill Investments, LLC | 25,500 | $269.0K | 0.03% | +25,500 | New |
| Wells Fargo & Company | 24,894 | $262.6K | 0.00% | +24,894 | New |
| Balyasny Asset Management LLC | 22,009 | $232.2K | 0.00% | +22,009 | New |
| Two Sigma Investments, LP | 20,159 | $212.7K | 0.00% | +20,159 | New |
| Laurion Capital Management LP | 20,000 | $211.0K | 0.01% | +20,000 | New |
| Citigroup Inc | 16,668 | $175.8K | 0.00% | +16,668 | New |
| Qube Research & Technologies Ltd | 16,667 | $175.8K | 0.00% | +16,667 | New |
| JPMorgan Chase & Co | 13,747 | $145.0K | 0.00% | +13,747 | New |
| Northern Trust Corp | 13,053 | $137.7K | 0.00% | +13,053 | New |
| Jane Street Group, LLC | 12,330 | $130.1K | 0.00% | +12,330 | New |
| Teacher Retirement System of Texas | 10,000 | $106.0K | 0.00% | +10,000 | New |
| Legal & General Group Plc | 10,000 | $105.8K | 0.00% | +10,000 | New |
| Resolute Partners Group | 10,000 | $105.5K | 0.02% | +10,000 | New |
| Morgan Stanley | 9,205 | $97.1K | 0.00% | +9,205 | New |
| US Bancorp | 4,500 | $47.5K | 0.00% | +4,500 | New |
| Bank of America Corp | 3,149 | $33.2K | 0.00% | +3,149 | New |
| UBS Group AG | 1,680 | $17.7K | 0.00% | +1,680 | New |
| Assetmark, Inc | 952 | $10.0K | 0.00% | +952 | New |
| Tower Research Capital LLC (TRC) | 456 | $4.81K | 0.00% | +456 | New |
| Principal Securities, Inc. | 54 | $570 | 0.00% | +54 | New |
| Larson Financial Group LLC | 50 | $528 | 0.00% | +50 | New |
| Macquarie Group Ltd | 355 | $4 | 0.00% | +355 | New |